United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · Real-Time Price · USD
314.12
-8.82 (-2.73%)
Mar 18, 2025, 4:00 PM EST - Market closed
United Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | 1,195 | 984.8 | 727.3 | 475.8 | 514.8 | Upgrade
|
| Depreciation & Amortization | 72.5 | 53.2 | 51.3 | 49.9 | 49.9 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 3.6 | 11.2 | 132.6 | 5.4 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | -5.4 | -90.3 | 5.7 | Upgrade
|
| Stock-Based Compensation | 144 | 39.1 | 106.8 | 138.5 | 163.8 | Upgrade
|
| Other Operating Activities | -24.3 | -4.9 | 52.5 | 65.9 | -47 | Upgrade
|
| Change in Accounts Receivable | -0.4 | -58.5 | -21.7 | -41.3 | -6 | Upgrade
|
| Change in Inventory | -46.9 | -13.6 | -13.4 | -7.5 | 10.3 | Upgrade
|
| Change in Accounts Payable | 42.7 | 57.1 | 44.5 | -12.5 | 38.6 | Upgrade
|
| Change in Other Net Operating Assets | -55.6 | -82.8 | -150.6 | -112.9 | 20.2 | Upgrade
|
| Operating Cash Flow | 1,327 | 978 | 802.5 | 598.2 | 755.7 | Upgrade
|
| Operating Cash Flow Growth | 35.70% | 21.87% | 34.15% | -20.84% | - | Upgrade
|
| Capital Expenditures | -246.5 | -230.4 | -138.8 | -120.8 | -59.3 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | - | 2.4 | Upgrade
|
| Cash Acquisitions | - | -89.2 | - | - | - | Upgrade
|
| Investment in Securities | 692.2 | -377 | -676.2 | -366.1 | -681.6 | Upgrade
|
| Other Investing Activities | -28.5 | -23 | 3.5 | - | - | Upgrade
|
| Investing Cash Flow | 417.2 | -719.6 | -811.5 | -486.9 | -738.5 | Upgrade
|
| Long-Term Debt Issued | - | - | 800 | - | - | Upgrade
|
| Total Debt Issued | - | - | 800 | - | - | Upgrade
|
| Long-Term Debt Repaid | -400 | -100 | -800 | - | -50 | Upgrade
|
| Total Debt Repaid | -400 | -100 | -800 | - | -50 | Upgrade
|
| Net Debt Issued (Repaid) | -400 | -100 | - | - | -50 | Upgrade
|
| Issuance of Common Stock | 160.1 | 104.6 | 94.3 | 55.6 | 38.5 | Upgrade
|
| Repurchase of Common Stock | -1,012 | -13.8 | -11.4 | -10.8 | -3.7 | Upgrade
|
| Other Financing Activities | -2.7 | -2.7 | -7.5 | - | -1.7 | Upgrade
|
| Financing Cash Flow | -1,255 | -11.9 | 75.4 | 44.8 | -16.9 | Upgrade
|
| Net Cash Flow | 489.5 | 246.5 | 66.4 | 156.1 | 0.3 | Upgrade
|
| Free Cash Flow | 1,081 | 747.6 | 663.7 | 477.4 | 696.4 | Upgrade
|
| Free Cash Flow Growth | 44.54% | 12.64% | 39.02% | -31.45% | - | Upgrade
|
| Free Cash Flow Margin | 37.55% | 32.12% | 34.28% | 28.32% | 46.95% | Upgrade
|
| Free Cash Flow Per Share | 22.28 | 15.04 | 13.68 | 10.09 | 15.61 | Upgrade
|
| Cash Interest Paid | 40.2 | 56 | 29.1 | 16.2 | 20.7 | Upgrade
|
| Cash Income Tax Paid | 400.6 | 332.5 | 275.7 | 153.3 | 92.8 | Upgrade
|
| Levered Free Cash Flow | 824.73 | 611.99 | 506.28 | 406.69 | 669.16 | Upgrade
|
| Unlevered Free Cash Flow | 851.54 | 649.05 | 526.53 | 418.31 | 683.85 | Upgrade
|
| Change in Net Working Capital | 22.4 | -45.9 | 110.9 | 78.6 | -156.7 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.